Knockdown of TERC disrupts the assembly and nuclear transport of the telomerase complex, resulting in telomere shortening, decreased NSCLC cell proliferation, and reduced expression of oncogenic factors such as c-Myc, Cyclin D1, and VEGF [157]. This evidence concerns the gene TERC and non-small cell lung carcinoma.